PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,771.00
Ask: 1,771.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.028%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-Former Tencent employees, including Alibaba exec, held in China graft probe

Fri, 10th Jul 2015 10:42

(Adds latest statements from companies, details)

By Paul Carsten and Arathy S Nair

BEIJING/BENGALURU, July 10 (Reuters) - Chinese authoritieshave detained about half a dozen former employees of TencentHoldings Ltd for alleged corruption and bribery, aswell as a current Alibaba Group Holding Ltd executive,the two companies said.

Amid a continuing crackdown on corruption by ChinesePresident Xi Jinping, Tencent said in a statement on Friday"five or six" people were detained, including two surnamed Zhangand Yue.

"An internal investigation brought to light bribery andcorruption among some online video employees ... The police havebeen notified and we are waiting for the results," the companysaid in a previous statement.

The alleged wrongdoing occurred when current Alibabaexecutive Patrick Liu was heading the social networking andentertainment firm's online video unit, according to Tencent.

An Alibaba spokeswoman said late on Thursday that Liu wastaken into custody by the Public Security Bureau.

Liu could not be reached for comment.

E-commerce giant Alibaba and Tencent, China's biggest socialnetworking and entertainment firm, are the country's two biggestInternet companies. The two have clashed with increasingfrequency as they move away from their core businesses and bothpush into areas like online entertainment, spending hundreds ofmillions of dollars on video streaming platforms and music.

"We understand Patrick Liu with our digital entertainmentunit has been detained by the authorities," Alibaba spokesmanBob Christie said in an email. "This issue is related to histime at Tencent and has nothing to do with Alibaba."

Liu and other former members of Tencent's video businessleft the company in 2013 and joined Alibaba later that year.

Tencent and Liu went to court in 2014 over a contractdispute concerning a confidentiality and non-compete agreementwhich Liu unsuccessfully tried to appeal against, according toofficial Chinese court records.

Alibaba said on its official Weibo microblog it was"extremely shocked" by the detention of Liu, who is also anexecutive director at Alibaba Pictures Group Ltd.

Alibaba has arranged for Liu's duties to be handled in hisabsence to protect Alibaba Pictures' shareholders, will providehim with legal support and that young people make mistakes, thecompany said.

"Patrick Liu was a former member of Tencent's management,and is suspected of corruption while in his position - this farexceeds the boundaries of making mistakes and violated thecompany's rules, as well as violating the law," Tencent said inits own Weibo post on Friday.

"Making mistakes can be forgiven, but how can breaking thelaw be tolerated?" (Editing by Stephen Coates and Kenneth Maxwell)

More News
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 19:02

Moderna says it hit its 2023 COVID vaccine sales goal

Jan 8 (Reuters) - Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated its goal of returning to sales growth in 2025.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.